Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-06-07
1997-03-04
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
514387, A61K 5104
Patent
active
056076592
ABSTRACT:
The present invention provides methods for directing the biodistribution of molecules that are not generally specifically excreted via the renal pathway to renal excretion. The methods employ conjugates or complexes containing a directed biodistribution molecule (DBM) and one or more bound molecules, wherein the biodistribution of the conjugate or complex is directed to renal excretion in vivo by the DBM component thereof.
REFERENCES:
patent: 4385046 (1983-05-01), Milbrath et al.
patent: 4732974 (1988-03-01), Nicolotti et al.
patent: 4849208 (1989-07-01), Stavrianopoulos
patent: 4855353 (1989-08-01), Kurami et al.
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 4985233 (1991-01-01), Klaveness et al.
patent: 5026785 (1991-06-01), Mage et al.
patent: 5053503 (1991-10-01), Dean et al.
patent: 5057313 (1991-10-01), Shih et al.
patent: 5153265 (1992-10-01), Shadle et al.
patent: 5162505 (1992-11-01), Dean et al.
patent: 5420105 (1995-05-01), Gustavson et al.
patent: 5482698 (1996-01-01), Griffiths
patent: 5525338 (1996-06-01), Goldenberg
International Search Report issued in PCT/US94/01036.
Torchilin et al., Journal of Controlled Release vol. II, pp. 297-303, Jan. 1990.
Armitage et al., Bioconjugate Chem., vol. 1, pp. 365-374, 1990, "Polymeric Contrast Agents for Magnetic Resonance Imaging: Synthesis and Characterization of Gadolinium Diethylenetriaminepentaacetic Acid Conjugated to Polysaccharides".
Krenning et al., J. Nucl. Med., vol. 33, pp. 652-658, 1992, "Somatostatin Receptor Scintigraphy with Indium-111-D-Phe-1-Octreotide in Man: Metabolism, Dosimetry and Comparison with Iodine-123-Tyr-3-Octreotide".
Midoux et al., Bioconjugate Chem., vol. 3 pp. 194-199, 1992, "Activation of Mouse Macrophages by Muramyl Dipeptide Coupled with an Anti-Macrophage Monoclonal Antibody".
Torchilin et al., J. Controlled Release, vol. 11, pp. 297-303, 1990, "Antibody-Linked Chelating Polymers for Immunoimaging In-Vivo".
Persiani et al., Carcinogenesis, vol. 12, pp. 1149-1152, 1991, "Polylysine conjugates of Bowman-Birk protease inhibitor as targeted anti-carcinogenic agents".
Khaw et al., J. Nucl. Med., Abstract No. 461, vol. 33, p. 934, 1992, "A New Approach to Imaging Experimental Atherosclerotic Lesions with Monoclonal Antibody Z3D3": Enhanced Targeting Utilizing Antibody-Avidin-Biotin Interactions.
Gansow, Nucl., Abstract No. 9, 1992 "Medical Application of Generator Produced Radionuclides: Current Clinical Results with Antibodies and Future Directions".
del Rosario et al., J. Nucl. Med., Abstract No. 356, vol. 32, p. 993, 1991 "Bolton-Hunter and Biotin Derivatized Polylysine: A new Multi-valent Peptide Reagent for In-Vivo Pre-targeting with Streptavidin Conjugates."
Hurwitz et al., Bioconjugate Chem., vol. 1. pp. 285-290, 1990, "A Conjugate of 5-Fluorouridine-Poly(L-lysine) and an Antibody Reactive with Human Colon Carcinoma".
Takakura et al., Pharmaceutical Research, vol. 7, pp. 339-346, 1990, "Disposition Characteristics of Macromolecules in Tumor-Bearing Mice".
Pithayanukul et al., Pharm. Bull., vol. 37, pp. 1587-1590, 1989, "In Vitro pH-Dependent Drug Release from N.sup.4 -(4-Carboxybutyryl)-1-B-arabinofurano-sylcytosine and Its Conjugate with Poly-L-lysine or Decylenediamine-dextran T70".
Manabe et al., Biochemical and Biophysical Research Communications, vol. 115, pp. 1009-1014, 1983, "Production of Monoclonal Antibody-Bleomycin Conjugate Utilizing Dextran T-40 and the Antigen-Targeting Cytotoxicity of the Conjugate".
Hurwitz et al., J. Med. Chem., vol. 28, pp. 137-140, 1985, "The Covalent Linking of Two Nucleotide Analogues to Antibodies".
Hurwitz et al., J. Applied Biochem., vol. 2, pp. 25-35, 1980, "Soluble Macromolecules as Carriers for Daunorubicin".
Fritzberg Alan R.
Gustavson Linda M.
Chapman Lara E.
Hollinden Gary E.
NeoRx Corporation
LandOfFree
Directed biodistribution of radiolabelled biotin using carbohydr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Directed biodistribution of radiolabelled biotin using carbohydr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Directed biodistribution of radiolabelled biotin using carbohydr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2144234